Cardiol Therapeutics (CRDL) Debt Ratio (2021 - 2026)

Cardiol Therapeutics has reported Debt Ratio for 6 years, with the latest figure at 0.12 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio changed N/A year-over-year to 0.12; the trailing twelve-month figure through Mar 2026 stood at 0.12 (changed N/A YoY), and the FY2025 full-year result was 0.09, changed N/A from the prior year.
• Debt Ratio for Q1 2026 stood at 0.12, up from 0.09 in the prior quarter.
• The five-year high for Debt Ratio was 0.12 in Q1 2026, with the low at 0.0 in Q3 2024.
• Historically, Debt Ratio has averaged 0.04 across 5 years, with a median of 0.03 in 2022.
• The largest YoY upside for Debt Ratio was 901.8% in 2024 against a maximum downside of 98.89% in 2024.
• Cardiol Therapeutics' Debt Ratio stood at 0.01 in 2022, then fell by 4.13% to 0.01 in 2023, then sank by 96.79% to 0.0 in 2024, then jumped by 43380.2% to 0.09 in 2025, then climbed by 29.01% to 0.12 in 2026.
• The last three Debt Ratio figures came in at 0.12 (Q1 2026), 0.09 (Q4 2025), and 0.0 (Q3 2024), per Business Quant data.